Rammurti T Kamble
Rammurti T Kamble
Associate Professor
  • :713-441-6353
  • :713-793-1232

Center for Cell and Gene Therapy
Houston Methodist Hospital
Baylor College of Medicine
USA

Education

November 1995 – February1996 Research Fellow, Bone marrow transplantation Hematology, LRF leukemia, Royal Postgraduate Medical School, Hammersmith Hospital London, UK, Following award of CSIR fellowship.
October1996–January 1997 UICC fellow in Bone Marrow transplantation Hematology, New York Hospital Cornell Medical Center, NY, Following award of UICC (ICRETT) fellowship (Geneva)
Jan.1988 to Dec.1990 Internal medicine residency Postgraduate Institute of Medical Education and Research (PGIMER) Chandigarh, India.
Aug.1991 to Sep.1994 Fellowship Medical Oncology/Hematology Hematology-Oncology, All India Institute for Medical Sciences (AIIMS), New Delhi, India.

 

Biography

Dr. Kamble is Associate Professor of Medicine in Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine and Methodist Hospital, Houston, TX. He graduated from Ravi Shankar University, India in 1986 with a gold medal. He obtained postgraduate residency training from prestigious Postgraduate Institute of Medical Science and Research (PGIMER) Chandigarh, India and his fellowship training in Hematology-Oncology from All India Institute of Medical Sciences (AIIMS), New Delhi. He was junior faculty in the AIIMS before joining MAMC, New Delhi University as Assistant Professor of Medicine. Between 1997 and 2001, he completed his residency and fellowship training in Internal Medicine

Research Interest

hematopoietic transplantation

Professional Activities:

Awards:

  1. UICC-ICRETT (Geneva) fellowship 1996 to spend 3 months of study in Bone marrow transplantation at New York hospital Cornell Medical Center, NY, beginning October 1996.
  2. CSIR (Central Scientific and Industrial Research) fellowship 1995 to spend 3 months study in Bone marrow transplantation in Hammersmith hospital London.
  3. University Gold Medal in Final MBBS for securing first position in the University examination held in 1986.
  4. College Silver Medal in second MBBS for securing first position in the University Examination held in 1984.

 

Publications

  1. Raina V, Kamble R, Tanwar R, Singh SP, Sharma S.Spinal ganglioneuroblastoma--complete response to chemotherapy alone. Postgrad Med J. 1993 Sep; 69(815): 746-8.
  2. Raina V, Singh SP, Kamble R, Tanwar R, Rao K, Dawar R, Rath GK.Brain metastasis as the site of relapse in germ cell tumor of testis.
    Cancer. 1993 Oct 1; 72(7): 2182-5.
  3. R. Kamble, R. Tanwar, A. Sharma and V. Raina. Ebstein Barr Virus related Oncogenesis. A Review. Specialist. 1994; 11:165-168.
  4. Kumar L, Kumar S, Kamble RM, Sharma S.Extra gonadal germ cell tumors: report of two cases. Asia Oceania J Obstet Gynaecol. 1994 Sep; 20(3): 257-62.
  5. R. Kamble, R.K Tanwar and Baharul Islam. Unusual late isolated CNS relapse in Seminoma Testis. A case report and review of literature. Surgical Journal of Pediatric and Medical Oncology.1995; 70:121-124.
  6. R. Kamble, A. Sharma, L Kumar, BM Biswal, MC Sharma and MS Sandhu. Cutaneous metastases disclosing lung cancer: Report of 6 cases and review of literature. Indian J. of Chest and Allied Diseases. 1995; 37:171-174
  7. R. Kamble, B. Islam, L.Kumar and V. Kochupillai. CNS toxicity of high dose Cytosar. Report of 2 cases and review of literature. Indian Journal of Pediatric and Medical Oncology.1995; 70:121-124.
  8. Kamble R, Kumar L, Kochupillai V, Sharma A, Sandhoo MS, Mohanti BK. Cutaneous metastases of lung cancer. Postgrad Med J. 1995 Dec; 71(842): 741-3.
  9. R. Kamble, R. Tanwar and Baharul Islam. Extra-nodal stage IE Non-Hodgkin’s lymphoma of paranasal sinus. Report of 7 cases and review of literature. Specialist 1995; 12:1-5.
  10. Sharma A, Kamble R, Kumar L, Bhargava B, Biswal BM, Kochupillai V. Palliative treatment of malignant pericardial effusion: report of two cases and a review of the literature. Support Care Cancer. 1996 Jul; 4(4): 317-9.
  11. Sharma A, Kumar L, Sandhu MS, Kamble R and Sharma S. Pulmonary blastoma: A case report and review of chemotherapy experience. Indian Journal of Medical and Paediatric Oncology. 1996 Mar; 17(1): 50-6
  12. Sandhu M, Sharma MC, Kamble RM. A diagnostic dilemma: pulmonary blastoma.
    Indian J Chest Dis Allied Sci. 1996 Oct-Dec; 38(4): 249-52.
  13. Kamble R, Raju GM, Kumar L, Kochupillai V.Blood stem cell transplantation: current concepts. Indian J Med Res. 1997 Jan; 105:1-8.
  14. Kamble R, Kochupillai V, Sharma A, Kumar L, Thulkar S, Sharma MC, Mittal S.Granulocytic sarcoma of uterine cervix as presentation of acute myeloid leukemia: a case report and review of literature. J Obstet Gynaecol Res. 1997 Jun; 23 (3): 261-6.
  15. JF Armor, J Fazili, N Toubia, W Kern, R Kamble, MA Kharfan-Dabaja. Remission of Natural-Killer Cell Lymphoma of the Liver with anti-Hepatitis C Therapy American Journal of Hematology. 2005;78:212-215
  16. R. Kamble MD, S. Sethi MD, GB Selby, MD. Failure to engraft after autologus stem cell transplantation: Possible therapeutic role of cyclosporine.  Biology of blood and marrow transplantation. 2005; 11:74.
  17. R Kamble, S Pant, GB. Selby, MA. Kharfan-Dabaja, S Sethi, S Lind, K Kratochvil, N Kohrt and H Ozer. Microbial Contamination of Hematopoietic Stem Cells Grafts: Incidence, Clinical Outcome and Cost-effectiveness: An analysis of 735 Grafts. Transfusion 2005; 45: 874-8.
  18. R. Kamble, A. Fassas, Carla Wilson, K.R. Desikan, D. Seigel, Paula Anderson, E.Anaissie and B.Barlogie. Malignant pleural effusion of Multiple Myeloma: Prognostic factors and outcome. Lymphoma Leukemia 2005; 46:1137-1142
  19. Kurkjian C, Armor JF, Kamble R, Ozer H, Kharfan-Dabaja MA. Symptomatic metastases to the pituitary infundibulum resulting from primary breast cancer. Int J Clin Oncol. 2005; 10: 191-4.
  20. Rammurti Kamble MD, Mehdi Hamadani MD and George Selby MD. Elevated Mean Corpuscular Volume (MCV) Following Autologous Hematopoietic Stem Cell Transplantation: Incidence and Significance. Biology of blood and marrow transplantation. 2006;12:111-112
  21. R. Kamble, T. Rosenzweig. Diffuse pulmonary parenchymal involvement in multiple myeloma: Ante-mortem diagnosis. International Journal of Hematology 2006; 83:259-261.
  22. R. Kamble, GB Selby, M. Mims, MA Kharfan-Dabaja, H. Ozer and JN George. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Biology of blood and marrow transplantation 2006; 12: 506-510.
  23. Terence Dunn, Richard Allen, Francesca Bates, Carla Kurkjian, Rammurti Kamble, and Mohamed Kharfan-Dabaja Cytogenetic Changes Associated with Myelodysplastic Syndrome Affecting Bone Marrow Engraftment Analysis 
    J Mol Diagn 2006; 8: 288-294.
  24. Kurkjian C, Patel S, Kamble R, Dunn T, William Kern and Kharfan-Dabaja M.A.  Acute Promyelocytic leukemia and Constitutional Trisomy 21.Cancer Genetics and Cytogenetics 2006; 165:176-9.
  25. Rammurti T. Kamble, Erick Hjortsvang and George B.Selby. Leukemia Burden and Outcome of Allogeneic Transplant in Acute Myelogenous Leukemia. Biology of blood and marrow transplantation 2006;6:691-692
  26. Mehdi Hamadani, M. Kharfan-Dabaja, Rammurti Kamble, William Kern, Howard Ozer. Marginal Zone B-Cell Lymphoma of the Uterus. A Case report and Review of the literature. Journal of Oklahoma State Medical Association 2006; 99:152-154.
  27. R. Kamble, M. Hamadani and GB Selby. Delayed myeloid engraftment due to vancomycin in allogeneic transplant recipient. Journal of Antimicrobial Chemotherapy 2006; 57:795-796.
  28. R. Kamble, MD and M. Mims, MD, PhD. Iron-overload in long-term survivors of hematopoietic transplant. Bone marrow transplant 2006; 37: 805-6.
  29. R. T. Kamble, MD, C.K Tin-U, MD and G. Carrum, MD. Successful mobilization and transplantation of filgrastim mobilized hematopoietic stem cells in sickle cell-hemoglobin C disease. Bone marrow transplantation 2006; 37:1065-6.
  30. Mohamed A. Kharfan-Dabaja, Sunil A. Patel, Kiarash Kojouri, Jian Yang, Mehmood Hashmi, Nizar J. Bahlis, Adeboye O. Osunkoya, Rammurti Kamble, Howard Ozer and George B. Selby. Expression of the Vascular Endothelial Growth Factor (VEGF) Receptors 1 and 2 in acute Myeloid Leukemia: Feasibility of Immuno-histochemical Staining and Prognostic Implications. Clinical and Laboratory Oncology 2006; 28:254-8.
  31. R. Kamble, M. Oholendt, G. Carrum. Rituximab responsive acute graft-versus-host disease. Biolol of Bone marrow and Blood Transplant 2006; 11:1201-120
  32. R. Kamble, MD, Jeff Chang, MD and George Carrum, MD. Central Nervous System Graft Versus Host Disease. Bone marrow transplant 2007; 1:49-52.
  33. T. Vu, G. Carrum, G. Hutton, H. E Heslop, M.K Brenner and R. Kamble. Human Herpesvirus-6 Encephalitis following Allogeneic Hematopoietic Stem Cell Transplantation. Bone marrow transplant 2007; 39:705-9.
  34. RT Kamble, DA Clark, HN Leong, HE Heslop, MK Brenner and G. Carrum. Transmission of Integrated Human Herpesvirus-6 in Allogeneic Hematopoietic Transplantation. Bone marrow transplant 2007 Sep;40(6):563-6
  35. RT Kamble, C. Bollard, G. Demmler, PR LaSala and G. Carrum. Human Metapneumovirus infection in hematopoietic transplant recipient. Bone marrow transplant 2007 Oct;40(7):699-700
  36. Wen J, Feng Y, Huang W, Chen H, Liao B, Rice L, Preti HA, Kamble RT, Zu Y, Ballon DJ, Chang CC. Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition. Leuk Res. 2010; 34: 85-92.
  37. Hari PN, Majhail NS, Zhang MJ, Hassebroek A, Siddiqui F, Ballen K, Bashey A, Bird J, Freytes CO, Gibson J, Hale G, Holmberg L, Kamble R, Kyle RA, Lazarus HM, Lemaistre CF, Loberiza F, Maiolino A, McCarthy PL, Milone G, Omondi N, Reece DE, Seftel M, Trigg M, Vesole D, Weiss B, Wiernik P, Lee SJ, Rizzo JD, Mehta P. Race and Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. Biol Blood Marrow Transplant. 2010 16: 395-402
  38. Fenske TS, Hari PN, Carreras J, Zhang MJ, Kamble RT, Bolwell BJ, Cairo MS, Champlin RE, Chen YB, Freytes CO, Gale RP, Hale GA, Ilhan O, Khoury HJ, Lister J, Maharaj D, Marks DI, Munker R, Pecora AL, Rowlings PA, Shea TC, Stiff P, Wiernik PH, Winter JN, Rizzo JD, van Besien K, Lazarus HM, Vose JM. Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma. Biol Blood Marrow Transplant. 2009 Nov; 15(11):1455-64.
  39. Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, Kamble R, Copelan E, de Lima M, Gupta V, Keating A, Lazarus HM, Litzow MR, Marks DI, Maziarz RT, Rizzieri DA, Schiller G, Schultz KR, Tallman MS, Weisdorf D. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol. 2010 Aug 10; 28 (23):3730-8.
  40. Shafer JA, Heslop HE, Brenner MK, Carrum G, Wu MF, Liu H, Ahmed N, Gottschalk S, Kamble R, Leung KS, Myers GD, Bollard CM, Krance RA. Outcome of hematopoietic stem cell transplant as salvage therapy for Hodgkin's lymphoma in adolescents and young adults at a single institution. Leuk Lymphoma. 2010 Apr; 51(4):664-70.
  41. Savoldo B, Ramos CA, Liu E, Mims MP, Keating MJ, Carrum G, Kamble RT, Bollard CM, Gee AP, Mei Z, Liu H, Grilley B, Rooney CM, Heslop HE, Brenner MK, Dotti G. CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients. J. Clin Invest. 2011; 2; 121:1822-6.
  42. Vogl DT, Wang T, Pérez WS, Stadtmauer EA, Heitjan DF, Lazarus HM, Kyle RA, Kamble R, Weisdorf D, Roy V, Gibson J, Ballen K, Holmberg L, Bashey A, McCarthy PL, Freytes C, Maharaj D, Maiolino A, Vesole D, Hari P. Effect of Obesity on Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma. Biol Blood Marrow Transplant. 2011 May 11
  43. Kumar S, Zhang MJ, Li P, Dispenzieri A, Milone GA, Lonial S, Krishnan A, Maiolino A, Wirk B, Weiss B, Freytes CO, Vogl DT, Vesole DH, Lazarus HM, Meehan KR, Hamadani M, Lill M, Callander NS, Majhail NS, Wiernik PH, Nath R, Kamble RT, Vij R, Kyle RA, Gale RP, Hari P. Trends in allogeneic stem cell transplantation for multiple myeloma: a Center for International Blood and Marrow Transplant Research (CIBMTR) analysis..Blood. 2011Jun 20.
  44. Kamble RT, Guo S, Ramos CA, Carrum G. Acute gout at engraftment following hematopoietic transplantation. Am J Hematol. Am J Hematol. 2011 Nov; 86 (11):961-2.
  45. Ringdén O, Shrestha S, da Silva GT, Zhang MJ, Dispenzieri A, Remberger M, Kamble R, Freytes CO, Gale RP, Gibson J, Gupta V, Holmberg L, Lazarus H, McCarthy P, Meehan K, Schouten H, Milone GA, Lonial S, Hari PN. Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma. Bone Marrow Transplant. 2011 Sep 26
  46. Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Agnès Gautheret-Dejean, Hall CB, Kamble RT, Kuehl U, Lassner D, Lautenschlager I, Loomis KS, Luppi M, Lusso P, Medveczky PG, Montoya JG, Mori Y, Ogata M, Pritchett JC, Rogez S, Seto E, Ward KN, Yoshikawa T, Razonable RR. Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol. 2011 Nov 4. [Epub ahead of print]
  47. El Fakih R, Obi GA, Scholoff A, Carrum G, Kamble RT. Systemic effects of oral budesonide in hematopoietic transplant: implications of drug interaction with azoles. Bone Marrow Transplant. 2012 Feb 13. doi: 10.1038/bmt.2012.17. [Epub ahead of print]
  48. Ballen KK, Mendizabal AM, Cutler C, Politikos I, Jamieson K, Shpall EJ, Dey BR, Attar E, McAfee S, Delaney C, McCarthy P, Ball ED, Kamble R, Avigan D, Maziarz RT, Ho VT, Koreth J, Alyea E, Soiffer R, Wingard JR, Boussiotis V, Spitzer TR, Antin JH. Phase II Trial of Parathyroid Hormone following Double Umbilical Cord Blood Transplantation. Biol Blood Marrow Transplant. 2012 Jul 2.
  49. Buchbinder D, Nugent DJ, Brazauskas R, Wang Z, Aljurf MD, Cairo MS, Chow R, Duncan C, Eldjerou LK, Gupta V, Hale GA, Halter J, Hayes-Lattin BM, Hsu JW, Jacobsohn DA, Kamble RT, Kasow KA, Lazarus HM, Mehta P, Myers KC, Parsons SK, Passweg JR, Pidala J, Reddy V, Sales-Bonfim CM, Savani BN, Seber A, Sorror ML, Steinberg A, Wood WA, Wall DA, Winiarski JH, Yu LC, Majhail NS. Late Effects in Hematopoietic Cell Transplant Recipients with Acquired Severe Aplastic Anemia: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2012 Aug 1. [Epub ahead of print]
  50. Danner-Koptik KE, Majhail NS, Brazauskas R, Wang Z, Buchbinder D, Cahn JY, Dilley KJ, Frangoul HA, Gross TG, Hale GA, Hayashi RJ, Hijiya N, Kamble RT, Lazarus HM, Marks DI, Reddy V, Savani BN, Warwick AB, Wingard JR, Wood WA, Sorror ML, Jacobsohn DA. Second malignancies after autologous hematopoietic cell transplantation in children. Bone Marrow Transplant. 2012 Sep 10. doi: 10.1038/bmt.2012.166. [Epub ahead of print]
  51. Kamble RT.Orthotopic heart transplant facilitated autologous hematopoietic stem cell transplantation in light-chain amyloidosis. Methodist Debakey Cardiovasc J. 2012 Jul; 8(3):17-8.
  52. Michaelis LC, Saad A, Zhong X, Le-Rademacher J, Freytes CO, Marks DI, Lazarus HM, Bird JM, Holmberg L, Kamble RT, Kumar S, Lill M, Meehan KR, Saber W, Schriber J, Tay J, Vogl DT, Wirk B, Savani BN, Gale RP, Vesole DH, Schiller GJ, Abidi M, Anderson KC, Nishihori T, Kalaycio ME, Vose JM, Moreb JS, Drobyski W, Munker R, Roy V, Ghobadi A, Holland HK, Nath R, To LB, Maiolino A, Kassim AA, Giralt SA, Landau H, Schouten HC, Maziarz RT, Michael J, Kindwall-Keller T, Stiff PJ, Gibson J, Lonial S, Krishnan A, Dispenzieri A, Hari P. Salvage Second Hematopoietic Cell Transplantation In Myeloma. Biol Blood Marrow Transplant. 2013 Jan 5. doi:pii: S1083-8791(13)00017-7. 10.1016/j.bbmt.2013.01.004. [Epub ahead of print]
  53. Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN, Hsu JW, Inwards DJ, Kamble RT, Klein A, Maharaj D, Marks DI, Rizzieri DA, Savani BN, Schouten HC, Waller EK, Wirk B, Lazarus HM. Allogeneic Hematopoietic Cell Transplantation For Chemotherapy-Unresponsive Mantle Cell Lymphoma: A Cohort Analysis From The Cibmtr. Biol Blood Marrow Transplant. 2013 Jan 17.
  54. Hamadani M, Saber W, Ahn KW, Carreras J, Cairo MS, Fenske TS, Gale RP, Gibson J, Hale GA, Hari PN, Hsu JW, Inwards DJ, Kamble RT, Klein A, Maharaj D, Marks DI, Rizzieri DA, Savani BN, Schouten HC, Waller EK, Wirk B, Laport GG, Montoto S, Maloney DG, Lazarus HM. Impact of Pretransplant Conditioning Regimens On Outcomes Of Allogeneic Transplantation For Chemotherapy-Unresponsisve Diffuse Large B-Cell Lymphoma And Grade-III Follicular Lymphoma. Biol Blood Marrow Transplant. 2013 Feb.2013.01.024. [Epub ahead of print]
  55. Loren AW, Brazauskas R, Chow EJ, Gilleece M, Halter J, Jacobsohn DA, Joshi S, Pidala J, Quinn GP, Wang Z, Apperley JF, Burns LJ, Hale GA, Hayes-Lattin BM, Kamble R, Lazarus H, McCarthy PL, Reddy V, Warwick AB, Bolwell BJ, Duncan C, Socie G, Sorror ML, Wingard JR, Majhail NS. Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2013 Feb 18. doi: 10.1038/bmt.2013.13. [Epub ahead of print]
  56. Bhagat RK, Zieske AW, Kamble RT.
  57. Cerebrospinal leukemoid reaction secondary to VZV meninigoencephalitis in an AML patient post allogeneic bone marrow transplantation. Blood. 2013 Jul 11; 122(2):300-301.
  58. Costa LJ, Zhang MJ, Zhong X, Dispenzieri A, Lonial S, Krishnan A, Freytes C, Vesole D, Gale RP, Anderson K, Wirk B, Savani B, Waller EK, Schouten H, Lazarus H, Meehan K, Sharma M, Kamble R, Vij R, Kumar S, Nishihori T, Kindwall-Keller T, Saber W, Hari PN Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma.Biol Blood Marrow Transplant. 2013 Aug 9. doi:pii: S1083-8791(13)00351-0. 10.1016/j.bbmt.2013.08.002
  59. Cruz CR, Micklethwaite KP, Savoldo B, Ramos CA, Lam S, Ku S, Diouf O, Liu E, Barrett AJ, Ito S, Shpall EJ, Krance RA, Kamble RT, Carrum G, Hosing CM, Gee AP, Mei Z, Grilley BJ, Heslop HE, Rooney CM, Brenner MK, Bollard CM, Dotti G. Infusion of donor-derived CD19-redirected-virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase I study. Blood. 2013 Sep 12. [Epub ahead of print]
  60. Copelan EA, Hamilton BK, Avalos B, Ahn KW, Bolwell BJ, Zhu X, Aljurf M, van Besien K, Bredeson CN, Cahn JY, Costa LJ, de Lima M, Gale RP, Hale GA, Halter J, Hamadani M, Inamoto Y, Kamble RT, Litzow MR, Loren AW, Marks DI, Olavarria E, Roy V, Sabloff M, Savani BN, Seftel M, Schouten HC, Ustun C, Waller EK, Weisdorf DJ, Wirk B, Horowitz MM, Arora M, Szer J, Cortes J, Kalaycio ME, Maziarz RT, Saber W. Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared to TBI.
  61. Blood. 2013 Sep 24
  62. Cox JE, Campos S, Wu J, May R, Liu H, Ramos CA, Carrum G, Heslop HE, Brenner MK, Kamble RT. Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma.Bone Marrow Transplant. 2013 Oct 7. doi: 10.1038/bmt.2013.149. [Epub ahead of print]
  63. Warlick SD, Paulson K, Brazauskas R, Zhong X, Miller AM, Camitta BM, George B, Savani BN, Ustun C, Marks DI, Waller EK, Baron F, Freytes CO, Socie G, Akpek G, Schouten HC, Lazarus HM, Horwitz EM, Koreth J, Cahn JY, Bornhauser M, Seftel M, Cairo MS, Laughlin MJ, Sabloff M, Ringdén O, Gale RP, Kamble RT, Vij R, Gergis U, Mathews V, Saber W, Chen YB, Liesveld JL, Cutler CS, Ghobadi A, Uy GL, Eapen M, Weisdorf DJ, Litzow MR. Effect of post remission therapy prior to reduced intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission. Biol Blood Marrow Transplant. 2013 Oct 31. doi:pii: S1083-8791(13)00500-4. 10.1016/j.bbmt.2013.10.023. [Epub ahead of print]
  64. Gupta V, Malone AK, Hari PN, Ahn KW, Hu ZH, Gale RP, Ballen KK, Hamadani M, Olavarria E, Gerds AT, Waller EK, Costa LJ, Antin JH, Kamble RT, van Besien KM, Savani BN, Schouten HC, Szer J, Cahn JY, de Lima MJ, Wirk B, Aljurf MD, Popat U, Bejanyan N, Litzow MR, Norkin M, Lewis ID, Hale GA, Woolfrey AE, Miller AM, Ustun C, Jagasia MH, Lill M, Maziarz RT, Cortes J, Kalaycio ME, Saber W. Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2013 Oct 23. doi:pii: S1083-8791(13)00495-3. 10.1016/j.bbmt.2013.10.018. [Epub ahead of print]
  65. Sobecks RM, Ahn KW, Zhu X, de Lima M, Brown JR, Inamoto Y, Holland HK, Aljurf MD, Laughlin MJ, Kamble RT, Hsu JW, Wirk BM, Seftel M, Lewis ID, Arora M, Alyea EP, Kalaycio ME, Cortes J, Maziarz RT, Gale RP, Saber W. Does Total Body Irradiation Conditioning Improve Outcomes of Myeloablative HLA-Identical Sibling Transplants for Chronic Lymphocytic Leukemia? Biol Blood Marrow Transplant. 2013 Dec 6. pii: S1083-8791(13)00569-7. doi: 10.1016/j.bbmt.2013.11.032. [Epub ahead of print]
  66. Saad A, Mahindra A, Zhang MJ, Zhong X, Costa LJ, Dispenzieri A, Drobyski WR, Freytes CO, Gale RP, Gasparetto CJ, Holmberg LA, Kamble RT, Krishnan AY, Kyle RA, Marks D, Nishihori T, Pasquini MC, Ramanathan M, Lonial S, Savani BN, Saber W, Sharma M, Sorror ML, Wirk BM, Hari PN. Hematopoietic Cell Transplant Comorbidity Index Is Predictive of Survival after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Biol Blood Marrow Transplant. 2013 Dec 14. pii: S1083-8791(13)01129-4. doi: 10.1016/j.bbmt.2013.12.557. [Epub ahead of print]
  67. Li X, Brazauskas R, Wang Z, Al-Seraihy A, Baker KS, Cahn JY, Frangoul HA, Gajewski JL, Hale GA, Hsu JW, Kamble RT, Lazarus HM, Marks DI, Maziarz RT, Savani BN, Shah AJ, Shah N, Sorror ML, Wood WA, Majhail NS. Avascular necrosis of bone following allogeneic hematopoietic cell transplantation in children and adolescents. Biol Blood Marrow Transplant. 2014 Jan 2. pii: S1083-8791(13)01182-8. doi: 10.1016/j.bbmt.2013.12.567. [Epub ahead of print]
  68. Wirk B, Fenske TS, Hamadani M, Zhang MJ, Hu ZH, Akpek G, Aljurf MD, Armand P, Ayala E, Bachanova V, Bolwell B, Cairo MS, Cashen A, Chen YB, Costa LJ, Farhan S, Freytes CO, Gajewski JL, Gibson J, Hale GA, Holmberg LA, Hsu JW, Inwards DJ, Kamble RT, Maharaj D, Maziarz RT, Munker R, Nath R, Reddy NM, Reeder CB, Rizzieri DA, Sauter CS, Savani BN, Schouten HC, Sureda A, Vose JM, Waller EK, Wiernik PH, Gale RP, Burns LJ, Saber W. Outcomes of Hematopoietic Cell Transplantation for Diffuse Large B Cell Lymphoma Transformed from Follicular Lymphoma.  Biol Blood Marrow Transplant. 2014 Mar 15. pii: S1083-8791(14)00163-3.
  69. Hamadani M, Hari PN, Zhang Y, Carreras J, Akpek G, Aljurf MD, Ayala E, Bachanova V, Chen AI, Chen YB, Costa LJ, Fenske TS, Freytes CO, Ganguly S, Hertzberg MS, Holmberg LA, Inwards DJ, Kamble RT, Kanfer EJ, Lazarus HM, Marks DI, Nishihori T, Olsson R, Reddy NM, Rizzieri DA, Savani BN, Solh M, Vose JM, Wirk B, Maloney DG, Smith SM, Montoto S, Saber W. Early Failure of Frontline Rituximab-containing Chemoimmunotherapy in Diffuse Large B-Cell Lymphoma does not Predict Futility of Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2014 Jul 4. pii: S1083-8791(14)00403-0
  70. Ringdén O, Brazauskas R, Wang Z, Ahmed I, Atsuta Y, Buchbinder D, Burns LJ, Cahn JY, Duncan C, Hale GA, Halter J, Hayashi RJ, Hsu JW, Jacobsohn DA, Kamble RT, Kamani NR, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Myers KC, Ramanathan M, Saber W, Savani BN, Schouten HC, Socie G, Sorror ML, Steinberg A, Popat U, Wingard JR, Mattsson J, Majhail NS. Second solid cancers after allogeneic hematopoietic cell transplantation using reduced intensity conditioning.Biol Blood Marrow Transplant. 2014 Jul 17. pii: S1083-8791(14)00435-2. doi: 10.1016/j.bbmt.2014.07.009.
  71. Sobecks RM, Leis JF, Gale RP, Ahn KW, Zhu X, Sabloff M, de Lima M, Brown JR, Inamoto Y, Hale GA, Aljurf MD, Kamble RT, Hsu JW, Pavletic SZ, Wirk B, Seftel MD, Lewis ID, Alyea EP, Cortes J, Kalaycio ME, Maziarz RT, Saber W. Outcomes of Human Leukocyte Antigen-Matched Sibling Donor Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia: Myeloablative Versus Reduced-Intensity Conditioning Regimens. Biol Blood Marrow Transplant. 2014 May 28. pii: S1083-8791(14)00318-8
  72. Kamble RT, Scholoff A, Obi AG, Heslop HE, Brenner MK, Carrum G. Neuropathic dermatomes and cutaneous ulceration in patients with chronic GVHD. Bone Marrow Transplant. 2014 Jul; 49(7):986-7.
  73. Hsu JW, Wingard JR, Logan BR, Chitphakdithai P, Akpek G, Anderlini P, Artz AS, Bredeson C, Goldstein S, Hale G, Hematti P, Joshi S, Kamble RT, Lazarus HM, O'Donnell PV, Pulsipher MA, Savani B, Schears RM, Shaw BE, Confer DL. Race and ethnicity influences collection of G-CSF mobilized peripheral blood progenitor cells from unrelated donors, a CIBMTR analysis. Biol Blood Marrow Transplant. 2014 Oct 11
  74. Duncan CN, Majhail NS, Brazauskas R, Wang Z, Cahn JY, Frangoul HA, Hayashi RJ, Hsu JW, Kamble RT, Kasow KA, Khera N, Lazarus HM, Loren AW, Marks DI, Maziarz RT, Mehta P, Myers KC, Norkin M, Pidala JA, Porter DL, Reddy V, Saber W, Savani BN, Schouten HC, Steinberg A, Wall DA, Warwick AB, Wood WA, Yu LC, Jacobsohn DA, Sorror ML. Long-term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Acute Leukemia and Myelodysplastic Syndromes
  75. Biol Blood Marrow Transplant. 2014 Oct 11
  76. Bachanova V, Burns LJ, Wang T, Carreras J, Gale RP, Wiernik PH, Ballen KK, Wirk B, Munker R, Rizzieri DA, Chen YB, Gibson J, Akpek G, Costa LJ, Kamble RT, Aljurf MD, Hsu JW, Cairo MS, Schouten HC, Bacher U, Savani BN, Wingard JR, Lazarus HM, Laport GG, Montoto S, Maloney DG, Smith SM, Brunstein C, Saber W. Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor. Bone Marrow Transplant. 2015; 50 (2):197-203. 
  77. Copelan EA, Avalos B, Ahn KW, Zhu X, Gale RP, Grunwald MR, Hamadani M, Hamilton BK, Hale GA, Marks DI, Waller EK, Savani BN, Costa LJ, Ramanathan M, Cahn JY, Khoury HJ, Weisdorf DJ, Inamoto Y, Kamble RT, Schouten HC, Wirk B, Litzow MR, Aljurf MD, van Besien KW, Ustun C, Bolwell BJ, Bredeson CN, Fasan O, Ghosh N, Horowitz MM, Arora M, Szer J, Loren AW, Alyea EP, Cortes J, Maziarz RT, Kalaycio ME, Saber W. Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan, or Total Body Irradiation. Biol Blood Marrow Transplant. 2014 Dec 17. pii: S1083-8791(14)01410-4
  78. Mahindra A, Raval G, Mehta P, Brazauskas R, Zhang MJ, Zhong X, Bird JM, Freytes CO, Hale GA, Herzig R, Holmberg LA, Kamble RT, Kumar S, Lazarus HM, Majhail NS, Marks DI, Moreb JS, Olsson R, Saber W, Savani BN, Schiller GJ, Tay J, Vogl DT, Waller EK, Wiernik PH, Wirk B, Lonial S, Krishnan AY, Dispenzieri A, Brandenburg NA, Gale RP, Hari P. New Cancers after Autotransplantations for Multiple Myeloma. Biol Blood Marrow Transplant. 2014 Dec 31. pii: S1083-8791(14)01472-4
  79. Inamoto Y, Shah NN, Savani BN, Shaw BE, Abraham AA, Ahmed IA, Akpek G, Atsuta Y, Baker KS, Basak GW, Bitan M, DeFilipp Z, Gregory TK, Greinix HT, Hamadani M, Hamilton BK, Hayashi RJ, Jacobsohn DA, Kamble RT, Kasow KA, Khera N, Lazarus HM, Malone AK, Lupo-Stanghellini MT, Margossian SP, Muffly LS, Norkin M, Ramanathan M, Salooja N, Schoemans H, Wingard JR, Wirk B, Wood WA, Yong A, Duncan CN, Flowers ME, Majhail NS. Secondary solid cancer screening following hematopoietic cell transplantation. Bone Marrow Transplant. 2015 Mar 30. doi: 10.1038/bmt.2015.63
  80. Goyal SD, Zhang MJ, Wang HL, Akpek G, Copelan EA, Freytes C, Gale RP, Hamadani M, Inamoto Y, Kamble RT, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Reshef R, Ritchie DS, Saber W, Savani BN, Seber A, Shea TC, Tallman MS, Wirk B, Bunjes DW, Devine SM, de Lima M, Weisdorf DJ, Uy GL. Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome. Bone Marrow Transplant. 2015 Apr 27. doi: 10.1038/bmt.2015.82.
  81. Zhou X, Dotti G, Krance RA, Martinez CA, Naik S, Kamble RT, Durett AG, Dakhova O, Savoldo B, Di Stasi A, Spencer DM, Lin YF, Liu H, Grilley BJ, Gee AP, Rooney CM, Heslop HE, Brenner MK. Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation. Blood. 2015 May 14. pii: blood-2015-02-628354.
  82. Shaw BE, Logan BR, Kiefer DM, Chitphakdithai P, Pedersen TL, Abdel-Azim H, Abidi MH, Akpek G, Diaz MA, Artz AS, Dandoy C, Gajewski JL, Hematti P, Kamble RT, Kasow KA, Lazarus HM, Liesveld JL, Majhail NS, O'Donnell PV, Olsson RF, Savani BN, Schears RM, Stroncek DF, Switzer GE, Williams EP, Wingard JR, Wirk BM, Confer DL, Pulsipher MA. An Analysis of the Effect of Race, Socioeconomic Status and Center Size on Unrelated NMDP Donor Outcomes: Donor Toxicities are More Common at Low Volume Bone Marrow Collection Centers. Biol Blood Marrow Transplant. 2015 Jun 23.
  83. Satwani P, Ahn KW, Carreras J, Abdel-Azim H, Cairo MS, Cashen A, Chen AI, Cohen JB, Costa LJ, Dandoy C, Fenske TS, Freytes CO, Ganguly S, Gale RP, Ghosh N, Hertzberg MS, Hayashi RJ, Kamble RT, Kanate AS, Keating A, Kharfan-Dabaja MA, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Prestidge TD, Rolon JM, Savani BN, Vose JM, Wood WA, Inwards DJ, Bachanova V, Smith SM, Maloney DG, Sureda A, Hamadani M. A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma. Bone Marrow Transplant. 2015 Aug 3. doi: 10.1038/bmt.2015.177. [Epub ahead of print]
  84. Uy GL, Costa LJ, Hari PN, Zhang MJ, Huang JX, Anderson KC, Bredeson CN, Callander NS, Cornell RF, Perez MA, Dispenzieri A, Freytes CO, Gale RP, Garfall A, Gertz MA, Gibson J, Hamadani M, Lazarus HM, Kalaycio ME, Kamble RT, Kharfan-Dabaja MA, Krishnan AY, Kumar SK, Kyle RA, Landau HJ, Lee CH, Maiolino A, Marks DI, Mark TM, Munker R, Nishihori T, Olsson RF, Ramanathan M, Rodriguez TE, Saad AA, Savani BN, Schiller GJ, Schouten HC, Schriber JR, Scott E, Seo S, Sharma M, Ganguly S, Stadtmauer EA, Tay J, To LB, Vesole DH, Vogl DT, Wagner JL, Wirk B, Wood WA, D'Souza A. Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation. Bone Marrow Transplant. 2015 Aug 24. doi: 10.1038/bmt.2015.190.
  85. Pasquini MC, Zhang MJ, Medeiros BC, Armand P, Hu ZH, Nishihori T, Aljurf MD, Akpek G, Cahn JY, Cairo MS, Cerny J, Copelan EA, Deol A, Freytes CO, Gale RP, Ganguly S, George B, Gupta V, Hale GA, Kamble RT, Klumpp TR, Lazarus HM, Luger SM, Liesveld JL, Litzow MR, Marks DI, Martino R, Norkin M, Olsson RF, Oran B, Pawarode A, Pulsipher MA, Ramanathan M, Reshef R, Saad AA, Saber W, Savani BN, Schouten HC, Ringdén O, Tallman MS, Uy GL, Wood WA Jr, Wirk B, Pérez WS, Batiwalla M, Weisdorf DJ. Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies. Biol Blood Marrow Transplant. 2015 Aug 29. pii: S1083-8791(15)00572-8.
  86. D'Souza A, Dispenzieri A, Wirk B, Zhang MJ, Huang J, Gertz MA, Kyle RA, Kumar S, Comenzo RL, Peter Gale R, Lazarus HM, Savani BN, Cornell RF, Weiss BM, Vogl DT, Freytes CO, Scott EC, Landau HJ, Moreb JS, Costa LJ, Ramanathan M, Callander NS, Kamble RT, Olsson RF, Ganguly S, Nishihori T, Kindwall-Keller TL, Wood WA, Mark TM, Hari P. Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study. J Clin Oncol. 2015 Sep 14. pii: JCO.2015.62.4015.
  87. Klyuchnikov E, Bacher U, Woo Ahn K, Carreras J, Kröger NM, Hari PN, Ku GH, Ayala E, Chen AI, Chen YB, Cohen JB, Freytes CO, Gale RP, Kamble RT, Kharfan-Dabaja MA, Lazarus HM, Martino R, Mussetti A, Savani BN, Schouten HC, Usmani SZ, Wiernik PH, Wirk B, Smith SM, Sureda A, Hamadani M. Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma. Bone Marrow Transplant. 2015 Oct 5. doi: 10.1038/bmt.2015.223

Abstracts:

  1. Kumar L., Kochupillai V., Raju GMK. Sharma A., Chandi L., Nandi M., Kataria S.P. and R. Kamble. GM-CSF in Bone marrow transplantation: Experience at the Institute Rotary Cancer Hospital. Blood. 1994; Nov. 1-15 abstract 85.
  2. Desikan, K.R., Dhodapkar, M., Siegel, D., Fassas, A., Singh, J., Singhal, S., Mehta, D., Vesole, D., Tricot, G., Jagannath, S., Kamble, R., Anaissie, E.J., Munshi, N., Barlogie, B. (1998) High-dose therapy with autologous blood stem cell support for Waldenström's macroglobulinemia: a pilot study.  Blood. 1998, 92, 660a.
  3. R. T. Kamble, CS. Wilson, KR. Desikan, A. Fassas, DS Siegel, J. Sawyer, E. Anaissie, G. Tricot and Bart Barlogie. Malignant Pleural Effusion in Multiple myeloma: Diagnosis, Treatment, and Outcome. Journal of Clinical Oncology, 2001 April, Abstract #1196
  4. M. Jafari, R. Kamble and JN George. Iron overload mimicking liver GVHD after allogeneic stem cell transplant: Response to Erythropoietin- assisted phlebotomy. Blood. 2003; 102: 721a (# 2666)
  5. S. Pant, R. Kamble, G. Selby, S. Lind, M. Kharfan-Dabaja, K. Kratochvil and H. Ozer. Microbial contamination of stem cells: Incidence, clinical importance and cost effectiveness of microbial surveillance in 735 stem cell collections. Blood. 2003; 102:462a (1684)
  6. S. Venkatappa, R. Kamble, G. Selby and H. Ozer. Bone marrow transplant in an adult with Schwachman Diamond Syndrome: A case report. Blood. 2003; 102: 334b (#5058)
  7. S. Sethi, R. Kamble, G. Selby, M. Kharfan-Dabaja, H. Ozer. Failure to engraft after autologus stem cell transplantation: Role of cyclosporine. Blood. 2003; 102: 335b (#5470)
  8. K. Kojouri, S. Pant, N. Kohrt, G. Selby, R. Kamble, H. Ozer and M. Kharfan-Dabaja. Early lymphocyte count recovery does not correlate with improved overall survival following autologus bone marrow/peripheral stem cell transplantation (BM/PSCT) in patients with relapsed/refractory Hodgkin’s lymphoma (R/R-HL). Blood. 2003; 102: 488b.
  9. Patel SA, Yang J, Kashef G, Kojouri K, Hashmi M, Selby GB, Ozer H, Kamble R and Kharfan-Dabaja MA. Prognostic significance of VEGF receptor I and II expression in patients with acute myeloid leukemia. JCO 2004; 23: 861 # 9623
  10. Mehdi Hamadani MD, Rammurti Kamble MD, Sanjay Sethi MD, Mohamed Kharfan-Dabaja MD, William Kern, Howard Ozer MD, PhD, and George Selby MD. Elevated Mean Corpuscular Volume (MCV) Following Autologous Hematopoietic Stem Cell Transplantation: Incidence and Significance. BBMT.2005; 11: 66 #198
  11. Sanjay Sethi, Mehdi H Hamadani, Rammurti Kamble, Mohamed Kharfan-Dabaja, Howard Ozer, and George B Selby. Pure Red Cell Aplasia (PRCA) following ABO incompatible allogeneic bone marrow transplantation. BBMT.2005; 11: 38 #110.
  12. R. Kamble, MD, E. Hjortsvang, S. Sethi, MK Kharfan-Dabaja, GB Selby and H. Ozer. Residual AML at the time of Allograft: outcome analysis based on number of marrow blasts. BBMT.2005; 11: 60 #180
  13. K. Kojouri, S. Pant, R. Kamble, N. Sylvester-Kohrt, G. B. Selby, H. Ozer, M. A. Kharfan-Dabaja. Significance of elevated serum lactate dehydrogenase (LDH) in patients undergoing salvage autologous bone marrow/peripheral stem cell transplantation (BM/PSCT) for relapsed/refractory Hodgkin's lymphoma (R/R-HL). Abstract-6734, JCO 2005 (#6734)
  14. K. Kojouri, C. El-Khoury, S. Pant, N. Sylvester-Kohrt, G.B. Selby, H. Ozer, R. Kamble and M.A. Kharfan-Dabaja. Prognostic Significance of Hypoalbuminemia in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Salvage Autologous Bone Marrow/Peripheral Stem Cell Transplantation. (Auto-BM/PSCT). Blood 2004 (5204)
  15. C. El-Khoury, K. Kojouri, S. Pant, N. Sylvester-Kohrt, G.B. Selby, H. Ozer, R. Kamble and M.A. Kharfan-Dabaja. Body mass index (BMI) as a prognostic factor in Patients with Relapsed/Refractory Hodgkin’s Lymphoma (R/R-HL) Undergoing Autologous Bone Marrow/Peripheral Stem Cell Transplantation. Blood 2004 (5206)
  16. Hjortsvang, E.W., Kharfan-Dabaja, M., Ozer, H., Selby, G.B., Kamble, R.T. Iron Overload Manifesting as Liver Graft Versus Host Disease Exacerbation: Response to Erythropoietin Assisted Phlebotomy. Biology of blood and marrow transplantation, Annual meeting of ASBMT 2006, abstract#107
  17. Vu, T., Kamble, R., Oholendt, M., Scholoff, A., Obi, G., East, K., Hutton, G., Heslop, H., Brenner, M., Carrum, G. Human Herpesvirus-6 Encephalitis Following Allogeneic Hematopoietic Stem Cell Transplantation. American society of bone marrow transplant proceeding 2007 (abstract # 278)
  18. Kamble, R., Phalak, K., Carrum, G., Oholendt, M., Heslop, H., Brenner, M. Rituximab Responsive Refractory Acute Graft Versus Host Disease. American society of bone marrow transplant proceeding 2007 (abstract # 304).
  19. East, K.A., Oholendt, M.S., Kamble, R., Carrum, G., Bross, A. Prophylactic Use of High Concentration Fluoride Rinse in the Hematopoietic Cell Transplant Patient: Promising Potential for Decreasing Oral Mucositis. American society of bone marrow transplant proceeding 2007 (abstract # 381).
  20. Oholendt, M.S., Darcourt, J., Kamble, R., Carrum, G. Triazole-Resistant Candida glabrata Oral Candidiasis and Associated Gastrointestinal Syndrome in Allogeneic Hematopoietic Cell Transplant: Successful Treatment with Oral Amphotericin B. American society of bone marrow transplant proceeding 2007 ( abstract # 427)
  21. RT Kamble, G. Carrum, L Rice, J McCarthy, K Baker, CA Ramos, H Androgue and J Estep. Orthotopic Heart Transplant Facilitated Autologous Hematopoietic Stem Cell Transplantation in Light-Chain Amyloidosis. Biology of Blood and Marrow Transplantation. Volume 18, Issue 2, Supplement , Pages S255-S256, February 2012
  22. Kamble R, Carrum G, Rice L, McCarthy JJ, Baker KR, Ramos CA and Estep J. Orthotopic heart transplant facilitated autologous hematopoietic stem cell transplantation in light-chain amyloidosis. Blood 2012;118(21):4489a
  23. Conrad Russell Y. Cruz, MD1*, Kenneth P. Micklethwaite, MD, PhD1*, Barbara Savoldo, MD, PhD1*, Stephanie Ku, BS1*, Robert A. Krance, MD1, Oumar Diouf, BS1*, Rammurti Kamble, MD1, A. John Barrett, MD2, Elizabeth J. Shpall, MD3, Helen E. Heslop, MD1, Cliona M. Rooney, PhD1*, Malcolm K. Brenner, MB, PhD, FRCP, FRCPath1, Catherine M. Bollard, MD1 and Gianpietro Dotti, MD1* Infusion of CD19-Directed and Multivirus Specific Cytotoxic T Lymphocytes After Allogeneic Hematopoietic Stem Cell Transplantation for B Cell Malignancies. Blood 2011 abstract # 4083
  24. Deferred Dosing of Granulocyte Colony Stimulating Factors in Autologous Hematopoietic Transplantation for Multiple Myeloma
    Stacy Campos, James Cox, Pharm D. , Romelia May, MF Wu, Hao Liu, PhD, Carlos A. Ramos, MD, Helen E. Heslop, MD, Malcolm K. Brenner, MD, PhD, George Carrum, MD, and Rammurti Kamble, MD, BBMT 2013; 19: S181 (abstract # 134)
  25. Long-Term Survival and Late Effects among 1-year Survivors of Second Allogeneic Hematopoietic Cell Transplantation (2nd Allo HCT) for Relapsed Acute Leukemia and Myelodysplastic Syndrome: A Report from the Center for International Blood     and Marrow Transplant Research (CIBMTR) Christine Duncan, MD; Navneet S. Majhail, MD, MS; Ruta Brazauskas, PhD; Zhiwei Wang, MS; Jean-Yves Cahn, MD; Rammurti T. Kamble, MD; Haydar A. Frangoul, MD; Robert J. Hayashi, MD; Jack W. Hsu, MD; David A. Jacobsohn, MD; Kimberly A. Kasow, DO; Nandita Khera, MD; Hillard M. Lazarus, MD; Alison W. Loren, MD, MS; Richard T. Maziarz, MD; Paulette Mehta, MD, MPH; Kasiani C. Myers, MD; Joseph Pidala, MD, MS; David L. Porter, MD; Vijay Reddy, MD; Wael Saber, MD, MS; Harry C. Schouten, MD; PhD; Amir Steinberg, MD; Lolie C. Yu, MD; Donna A. Wall, MD; Anne B. Warwick, MD, MPH; William A. Wood, MD, MPH; Bipin N. Savani, MD; Mohamed L. Sorror, MD, MSc BBMT 2014
  26. A Retrospective Review of Factor X Levels and Bleeding Risk in Patients with Amyloidosis. Anish S Konde, Charles Camposano, Mushtaq Farah, Puppala Mamta, Wong Solomon, George Carrum, McCarthy John, Kelty R. Baker, Jerry Estep, Arvind Bhimraj, Rammurti Kamble, Lawrence Rice, MD6 and Swaminathan Padmanabhan Iyer. Blood 2013 abstract #
  27. Orthotopic heart transplant facilitated autologous hematopoietic stem cell transplantation in light-chain amyloidosis. Kamble R, G. Obi, A. Scholoff, Carrum G, Rice L, A Bhimraj and Estep J. Lymphoma and Myeloma 2015 abstract #188

 

Autoimmune Journal Flyer